Oric Pharmaceuticals, Inc. — Director's Dealing 2021

May 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2021-05-20

Reporting Person: SCHELLER RICHARD H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-20	Common Stock	S	659	$25.0805	Disposed	40423	Direct
2021-05-21	Common Stock	S	1231	$25.1895	Disposed	39192	Direct
2021-05-24	Common Stock	S	100	$25.00	Disposed	39092	Direct

Footnotes

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Represents the weighted average share price of an aggregate total of 659 shares sold in the price range of $25.00 to $25.15 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 1,231 shares sold in the price range of $25.00 to $25.35 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.